Clinical Trial Update: Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating bromocriptine's effects on homeostatic and hedonic regulation of food intake in individuals at high risk for type 2 diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eating Disorders or Disordered Eating As Behavior Context
• Overweight or Obesity
• Type 2 Diabetes Risk Factors

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Overweight and Obesity, Eating Behavior | Phase 3 | Status: COMPLETED | Results posted: 2022-08-10